Evidence map›Paper›PMID 41290635›Full record

ArticleMicrosystems & nanoengineering2025

Fabrication of self-emulsifying lipid microstructure by stiffness-tunable mold for drug delivery applications.

Jongeon Park, Renaud Rovera, Arnaud Bertsch, Nicolas Zaugg, Hiba Hassoun, Evelyne Colomb, Claire Monge, Juergen Brugger

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jongeon ParkMicrosystems Laboratory (EPFL-STI-IEM-LMIS1) Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland. jongeon.park@epfl.ch.ORCID http://orcid.org/0000-0002-2893-584X
Renaud RoveraUMR 5305: Laboratory of Tissue Biology and Therapeutic Engineering (LBTI), Institute of Protein Biology and Chemistry, CNRS/Universite Claude Bernard Lyon 1, 7 Passage du Vercors, 69007, Lyon, France.
Arnaud BertschMicrosystems Laboratory (EPFL-STI-IEM-LMIS1) Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-1044-0478
Nicolas ZauggMicrosystems Laboratory (EPFL-STI-IEM-LMIS1) Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.
Hiba HassounUMR 5305: Laboratory of Tissue Biology and Therapeutic Engineering (LBTI), Institute of Protein Biology and Chemistry, CNRS/Universite Claude Bernard Lyon 1, 7 Passage du Vercors, 69007, Lyon, France.
Evelyne ColombUMR 5305: Laboratory of Tissue Biology and Therapeutic Engineering (LBTI), Institute of Protein Biology and Chemistry, CNRS/Universite Claude Bernard Lyon 1, 7 Passage du Vercors, 69007, Lyon, France.
Claire MongeUMR 5305: Laboratory of Tissue Biology and Therapeutic Engineering (LBTI), Institute of Protein Biology and Chemistry, CNRS/Universite Claude Bernard Lyon 1, 7 Passage du Vercors, 69007, Lyon, France. claire.monge@cnrs.fr.ORCID http://orcid.org/0000-0001-6715-2226
Juergen BruggerMicrosystems Laboratory (EPFL-STI-IEM-LMIS1) Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland. juergen.brugger@epfl.ch.ORCID http://orcid.org/0000-0002-7710-5930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amphiphilic lipid formulations, such as self-emulsifying drug delivery systems, offer advantages for enhancing drug release control and expanding their applicability across various administration routes. By integrating microfabrication techniques with these lipid-based systems, additional functionalities such as controlled drug release can be introduced. This can broaden lipid's potential for advanced biomedical and pharmaceutical applications. However, lipids face major fabrication challenges due to their thermolability, solvent incompatibility, and poor mechanical properties. Here, we present a novel microfabrication route for self-emulsifying lipid drug delivery systems based on thermal imprinting of a stiffness-tunable mold, which stays inflexible during the thermal imprinting step and softens upon swelling for the demolding step. The stiffness tuning process is reversible to some extent through a simple drying process, allowing reuse of the mold. The presented method resolves the issues of mechanical stress and lipid dissolution during the demolding process, enabling the scalable and cost-efficient fabrication of lipid microstructures down to 20 µm resolution and a 5:1 aspect ratio. As a proof-of-concept, we fabricated honeycomb-shaped self-emulsifying drug delivery lipid microstructures on a mucoadhesive film. Lipid microstructure increases the mechanical robustness and accelerates lipid dissolution for sublingual administration of poorly water-soluble drugs. In vivo testing in mouse models confirmed efficient mucosal penetration and submucosal drug accumulation, showing potential as sublingual drug delivery devices.

Identifiers

PMID41290635
PMCPMC12647786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.